Posts by: Sreetama Dutt

Sreetama Dutt

Sreetama Dutt is a news curator and columnist at Hepatitis News Today. She studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK.

May 5, 2015May 5, 2015

New Drug Shows Promise In Treating Chronic HCV Patients With Liver Transplant And Advanced Liver Disease

Hepatitis C, News

Hepatitis C is one of the worst forms of liver diseases affecting people in the world today — around 3.2 million have HCV in the United States alone. Spread mostly from ... Read more

May 1, 2015May 1, 2015

ALLY-1 Clinical Trial Results Suggest Viable Chronic Hepatitis C Virus Treatment

Hepatitis C, News

In a recent press release from Bristol-Myers Squibb, officials announced the success of their ongoing phase III clinical trial, ALLY-1, in meeting its predicted end-points. The trial had been conducted among ... Read more

April 22, 2015April 22, 2015

Cancer Drugs Being Tested To Combat Chronic Hepatitis B

Hepatitis B

Australia is on the verge of becoming a pioneer in formulating a possible cure for chronic Hepatitis B infections and related complications, like cirrhosis and liver cancer. According to a recent press ... Read more